Meeting
2023 ASCO Genitourinary Cancers Symposium
COVID-19 vaccines in patients with urothelial cancers receiving immune checkpoint inhibitors.
Authors
Danielle Gilbert
University of Colorado School of Medicine, Aurora, CO
Danielle Gilbert , Junxiao Hu , Elaine T. Lam
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer and Urothelial Carcinoma
Track
Urothelial Carcinoma,Prostate Cancer - Advanced
Sub Track
Symptoms, Toxicities, Patient-Reported Outcomes, and Whole-Person Care
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 491)
DOI
10.1200/JCO.2023.41.6_suppl.491
Abstract #
491
Poster Bd #
J13
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Breakthrough
The effect of corticosteroid on immunogenicity of SARS-CoV-2 vaccines in solid cancer patients.
First Author: Chayanee Samdaengpan
Poster
2023 ASCO Genitourinary Cancers Symposium
Clinical characteristics and outcomes of SARS-CoV-2 infection in patients with genitourinary cancer.
First Author: Dorothy Kenny
Poster
2022 ASCO Annual Meeting
Patient-reported toxicity and quality of life following Sars-CoV-2 vaccination in adults and children with cancer.
First Author: Amy Body
Poster
2023 ASCO Quality Care Symposium
Improving bivalent COVID-19 vaccination rates among adult patients with cancer: An ASCO/CDC initiative.
First Author: Michael Jisoo Lee